COMPUTERIZED BLOOD DONOR PROCESSING SYSTEM

计算机化献血者处理系统

• 批准号: 6390066
• 负责人: Paul David Cumming
• 金额: $ 48.36万
• 依托单位: TALISMAN, LTD
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-08-05 至 2003-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6390066
• 关键词: audiotape; blood bank /supply contamination; blood banks; blood donor; case history; communicable disease control; communicable disease diagnosis; computer assisted instruction; computer program /software; computer system design /evaluation; data management; human subject; interactive multimedia; mass screening; patient /disease registry; videotape /videodisc

Talisman's long term objective is to develop a fully integrated, automated blood donor processing system that will be the industry standard for quality, safety and cost-effectiveness. Aims of Phase II research are: 1) expand Talisman's current multimedia interactive video donor health history screening system into a fully integrated, automated donor processing system, 2) successfully implement the resultant system in three blood centers, 3) evaluate the system's commercial potential, and 4) assess its societal impacts. Research design and methods involve sequential design, development, testing and validation of computer based modules for all donor processing functions from registration, through screening and checkout. The research includes analysis of donors, staff and management reactions to the system, determination of the system's net cost-benefits, assessment of its domestic and foreign commercial potential, and evaluation of the system's capability of enhancing blood safety and increasing blood availability. The most innovative aspects of the research are the development and validation of a series of decision algorithms for determining donor suitability based on donor information regarding prior donation history, key health and behavioral characteristics, and outcome from a mini physical. The completed system will address 40% of blood banking costs and 60% of reportable errors. PROPOSED COMMERCIAL APPLICATIONS: With 25,000,000 annual US blood and plasma donations, and three or four times this market world wide, depending on automation cost savings and how potential implementers value benefits, the system could be worth tens of millions of dollars. If the system were successful in preventing just one donation that ultimately resulted in a product recall from entering a plasma pool, the value to the manufacturer could be in excess of $1,000,000.

Talisman 的长期目标是开发一种完全集成的自动化献血者处理系统，该系统将成为质量、安全和成本效益的行业标准。第二阶段研究的目标是：1) 将 Talisman 目前的多媒体交互式视频献血者健康史筛查系统扩展为完全集成的自动化献血者处理系统，2) 在三个血液中心成功实施最终系统，3) 评估该系统的商业潜力，4) 评估其社会影响。研究设计和方法涉及基于计算机的模块的顺序设计、开发、测试和验证，用于从注册到筛选和结账的所有捐赠者处理功能。该研究包括分析捐献者、工作人员和管理层对该系统的反应，确定该系统的净成本效益，评估其国内外商业潜力，以及评估该系统增强血液安全和增加血液可用性的能力。该研究最具创新性的方面是开发和验证一系列决策算法，用于根据有关先前捐赠历史、关键健康和行为特征以及迷你体检结果的捐赠者信息来确定捐赠者的适合性。完整的系统将解决 40% 的血库成本和 60% 的可报告错误。拟议的商业应用：美国每年有 25,000,000 人的血液和血浆捐赠，是全球市场的三到四倍，根据自动化成本节省和潜在实施者如何评估收益，该系统可能价值数千万美元。如果该系统成功地阻止了一次最终导致产品召回的捐赠进入血浆池，那么制造商的价值可能超过 1,000,000 美元。